| scholarly article | Q13442814 |
| P2093 | author name string | J Song | |
| W Brown | |||
| J Craft | |||
| B M Kacinski | |||
| J Nilsen | |||
| G Mor | |||
| E Sapi | |||
| F Naftolin | |||
| K Tartaro | |||
| P2860 | cites work | Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 |
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries | Q28308117 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The Fas death factor | Q29620461 | ||
| The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces | Q33687297 | ||
| Regulation of p53 and its targets during involution of the mammary gland | Q33699428 | ||
| Illegitimate transcription: transcription of any gene in any cell type | Q33849869 | ||
| Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. | Q34103424 | ||
| Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients | Q34203571 | ||
| Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. | Q34418845 | ||
| Illegitimate transcription: its use in the study of inherited disease | Q35221865 | ||
| Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution | Q36086481 | ||
| Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice | Q36129002 | ||
| Breast cancer (1) | Q36275386 | ||
| Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing | Q36363817 | ||
| p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs | Q36401199 | ||
| Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression | Q38287546 | ||
| Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. | Q39777499 | ||
| Fas and Fas ligand: a death factor and its receptor. | Q40398073 | ||
| Gangliosides and antitumor immunity | Q40771118 | ||
| Growth factors in breast cancer | Q40928040 | ||
| The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas | Q40935884 | ||
| Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells | Q41057634 | ||
| Human lung carcinomas express Fas ligand. | Q41120854 | ||
| Fas expression and function in normal and malignant breast cell lines. | Q41158790 | ||
| Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue | Q41674448 | ||
| Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. | Q41827712 | ||
| Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia | Q41842605 | ||
| Apoptotic cell death and tissue remodelling during mouse mammary gland involution | Q42462200 | ||
| FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier | Q48166557 | ||
| Cell death by apoptosis during involution of the lactating breast in mice and rats. | Q52487735 | ||
| Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. | Q52532134 | ||
| Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. | Q53439560 | ||
| Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice | Q53461594 | ||
| Deacetylase activity of human tumor cells producing immunosuppressive aminosugars: its possible role in resistance to cell-mediated cytotoxicity. | Q54224714 | ||
| Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice | Q58325254 | ||
| A role for CD95 ligand in preventing graft rejection | Q59066471 | ||
| Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege | Q63408406 | ||
| The JAM test. A simple assay for DNA fragmentation and cell death | Q67814814 | ||
| Macrophage recognition of cells undergoing programmed cell death (apoptosis) | Q69874470 | ||
| Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis | Q71556998 | ||
| Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling | Q71729471 | ||
| Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape | Q71762882 | ||
| Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver | Q71794021 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Programmed cell death during mammary gland involution | Q71873854 | ||
| History of lactation and breast cancer risk | Q72671604 | ||
| Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen | Q73169381 | ||
| p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta | Q73470584 | ||
| Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance | Q73476243 | ||
| Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors | Q73569253 | ||
| Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells | Q73668405 | ||
| Fas antigen-mediated apoptosis of ovarian surface epithelial cells | Q73826944 | ||
| Apoptosis and apoptosis-related proteins (Fas, Fas ligand, bcl-2, p53) in macrophages of human ovarian epithelial tumors | Q73868109 | ||
| Biological and molecular basis of human breast cancer | Q77195904 | ||
| Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease | Q77384771 | ||
| Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential | Q77391262 | ||
| The role of CSF-1 in normal and neoplastic breast physiology | Q77807727 | ||
| Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis | Q77921646 | ||
| Introduction: mammary gland involution and apoptosis of mammary epithelial cells | Q78060436 | ||
| Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies | Q93926133 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1209-1220 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Roles of Fas and Fas ligand during mammary gland remodeling | |
| P478 | volume | 106 |
| Q36041423 | Accelerated apoptosis in the Timp-3-deficient mammary gland |
| Q33618500 | Analysis of inhibitor of apoptosis protein family expression during mammary gland development |
| Q30923800 | Antiproliferative and apoptotic effect of TGF-β1 in bovine mammary epithelial BME-UV1 cells |
| Q28590802 | Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I |
| Q35854115 | Apoptosis regulation in the mammary gland |
| Q44878674 | Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients |
| Q24642170 | CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts |
| Q47804073 | Caspase-mediated Cleavage of Insulin Receptor Substrate |
| Q73040953 | Cell proliferation, apoptosis, and expression of Bcl-2 and Bax in non-lactating human breast epithelium in relation to the menstrual cycle and reproductive history |
| Q36066300 | Considering Fas ligand as a target for therapy |
| Q54975879 | Deciphering the roles of lncRNAs in breast development and disease. |
| Q40666021 | Early events in the anoikis program occur in the absence of caspase activation |
| Q28578235 | Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes |
| Q24794250 | Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression |
| Q82421627 | Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes |
| Q37119830 | Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis |
| Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
| Q44237377 | Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand |
| Q24802711 | IkB kinase alpha: a link in the chain of the mammary cycle |
| Q43718801 | Impaired lactation in mice expressing dominant-negative FADD in mammary epithelium |
| Q33316234 | Lactation failure in Src knockout mice is due to impaired secretory activation |
| Q24629797 | Mammary gland development |
| Q36790713 | Mammary gland involution as a multi-step process |
| Q37220983 | Mammary involution and breast cancer risk: transgenic models and clinical studies |
| Q40652949 | Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis |
| Q44315208 | Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer |
| Q36246907 | Modulation of TGF-beta signaling by EGF-CFC proteins |
| Q93193962 | Molecular mechanism of mammary gland involution: An update |
| Q34796595 | PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium |
| Q40650033 | Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells |
| Q40297064 | Proliferation-apoptosis balance in Staphylococcus aureus chronically infected bovine mammary glands during involution |
| Q44061475 | Regulation of Fas ligand expression by estrogen in normal ovary |
| Q47968611 | Regulation of FasL/Fas in Human Trophoblasts: Possible Implications for Chorioamnionitis1 |
| Q87367110 | Relationship between expression of hepatocyte grow factor and apoptosis of trophoblasts in hypertensive disorder complicating pregnancy |
| Q34977059 | Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis |
| Q28344847 | Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells |
| Q36375815 | Stromelysin-1 regulates adipogenesis during mammary gland involution |
| Q34067014 | TIMP3 regulates mammary epithelial apoptosis with immune cell recruitment through differential TNF dependence. |
| Q35297606 | The Fas/Fas ligand system and cancer: immune privilege and apoptosis |
| Q33884271 | The Signaling Mechanism of TGF-β1 Induced Bovine Mammary Epithelial Cell Apoptosis |
| Q28203717 | The TNF and TNF receptor superfamilies: integrating mammalian biology |
| Q36752770 | The beginning of the end: death signaling in early involution |
| Q34048057 | The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis |
| Q36327217 | The role of Fas mediated apoptosis in preeclampsia |
| Q38264904 | The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition |
| Q41134742 | The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL |
| Q24801183 | Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer |
Search more.